had achieved clear or almost clear skin, with 19.6% having no skin lesions at all week 16, rising to 26.2% after a year. Skyrizi – partnered with Boehringer Ingelheim – is already enjoying ...

"Advances in our understanding of psoriatic disease have brought us to an era where clear skin is a realistic treatment goal. "Skyrizi has the potential to help psoriasis patients achieve high ...

Protagonist Therapeutics broke out Monday after the company's drug topped its rival from Bristol in a psoriasis study.

(RTTNews) - AbbVie Inc. (ABBV) Tuesday said that its Skyrizi approved for the treatment of adults with moderately to severely active ulcerative colitis is now available in Canada. Ulcerative ...